Inventor
Walter Muller
Inventor
Neuwied, DE
Overview
Patents· 69 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
C09BOrganic dyes or closely-related compounds for producing dyes, e.g. pigments12%
A61LMethods or apparatus for sterilising materials or objects in general7%
A61FFilters implantable into blood vessels4%
C07DHeterocyclic compounds4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
A61MDevices for introducing media into, or onto, the body2%
C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients2%
C08LCompositions of macromolecular compounds1%
PatentTitleYear
10,940,122Transdermal therapeutic system with fentanyl or related substances202110,709,669Microreservoir system based on polysiloxanes and ambiphilic solvents202010,583,093Transdermal therapeutic system with fentanyl or related substances202010,568,845Transdermal therapeutic system with fentanyl or related substances202010,532,033Microreservoir system based on polysiloxanes and ambiphilic solvents202010,350,174Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine201910,251,844Transdermal therapeutic system and method of use thereof for treating parkinsonism201910,130,589Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine201810,034,841Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer of the system and use of said back layer20189,925,150'Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine'20189,180,103'Plaster having adjustable occlusion'20158,821,920'Therapeutic patch for transdermal delivery of capsaicin'20148,492,610'Transgeneic animal expressing a multiple mutated form of presenilin 1'20137,390,500'Transdermal therapeutic system (TTS) with fentanyl as a active ingredient'20086,899,894'Transdermal therapeutic system containing hormones and crystallization inhibitors'20056,884,434'Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof'20056,699,498'Transdermal therapeutic systems having improved stability and their production'20046,676,962'Topical plaster with non-steroidal antirheumatic agents with an acid group'20046,652,903'Dry-copying method for producing flat, individually dosed preparations of active agents'20036,620,429'Use of basic alkali metal salts for manufacturing transdermal therapeutic system'20036,537,571'Transdermal therapeutic system containing the active substance scopolamine base'20036,436,433'Transdermal or topical plaster system with a polyacrylate matrix with improved physical properties'20026,399,091'Wound dressing for the controlled release of active substance to wounds, and process for its manufacture'20026,333,048'Solid medicament form with active agent distributed in flat polymer fragments'20016,277,400'Extendible transdermal therapeutic system'20016,156,764'Morphine and diamorphine salts of anionic non-narcotic analgesics of the substituted carboxylic acid type'20006,114,347'Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorus cholinesterase inhibitors'20006,074,665'Transdermal therapeutic system for administering active agents to the human body via the skin'20005,939,095'Transdermal therapeutic system and a process for the combined transdermal application of physostigmine and scopolamine for the prophylaxis and pretreatment of a poisoning caused by highly toxic organophosphorus neurotoxins in particular soman'19995,902,433'Process and a device for producing a transdermal therapeutic system for the administration of active substances to the skin in the form of a plane multichamber or multichamber-channel system'19995,902,602'Estradiol-TTS having water-binding additives'19995,869,652'Process for producing active substances from unused or discarded devices for the transdermal administration'19995,858,344'Oral administration form having acid active substances and a process for its production'19995,802,972'Tampon printing process'19985,714,162'Scopolamine patch'19985,569,484'Process for producing a flat active substance administration form'19965,466,466'Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substrates II'19955,462,746'Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation'19955,458,885'Basic active component-permeable pressure sensitive adhesive polymer material process of the production thereof and use thereof'19955,413,567'Primary packaging for surface-stabilized surgical dressing'1995D0356134'Ball cleaner'19955,306,503'Patch with a high content of softening ingredients'19945,242,381'Application aid and the use thereof'19935,215,751'Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances (I)'19935,188,622'Vacuum bottle for collection of body fluids'19935,176,917'Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances'19935,128,137'Therapeutic system for the transdermal or transmucous administration of active substances and the use thereof'19925,106,757'Process for the visualization of substance stains on layer chromatograms'19925,077,055'Topical therapeutic system comprising 5-fluorouracil'19914,929,705'New polyisocyanate-polyaddition compounds, a process for their preparation and their use for the dispersion of solids'19904,721,745'Pigments based on metal complexes'19884,711,670'Moistening agent for offset printing plates'19874,709,019'Anthraquinone-azo pyridone-containing compounds'19874,628,093'Red nickel azine pigment'19864,614,547'Azine pigments'19864,564,680'Isoindolazines'19864,389,215'Anthraquinone-azomethine compounds, processes for their preparation and processes for dyeing synthetic fibre materials and for pigmenting organic macromolecular substances'19834,323,670'Anthraquinone-azomethine compounds, processes for their preparation and processes for pigmenting organic macromolecular substances'19824,323,671'Anthraquinone derivatives, processes for their preparation, processes for pigmenting organic macromolecular substances, and pigmented organic macromolecular material'19824,319,025'Anthraquinone-azomethine compounds, processes for their preparation and processes for dyeing synthetic fibre materials and for pigmenting organic macromolecular substances'19824,309,221'Anthraquinone derivatives'19824,288,362'Monoazo pigments containing a quinazo linonylacetoacetanilide coupling component'19814,284,411'Anthraquinone derivatives for pigmenting organic macromolecular substances'19814,260,540'Azo dye pigments containing 4-quinazolinone moieties'19814,246,401'Axomethine pigments'19814,225,489'Heterocyclic azo dyes and pigments containing 4-quinazolinone moieties'19804,026,990'Production of low-fluorine gypsum as a by-product in a phosphoric acid process'19774,008,234'Process for the preparation of melon'19773,960,541'Process for regulating or influencing the growth and metabolism of plants'1976Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1976–1977Patents assigned to CHEMIE LINZ AG (3)· patent assignee history
1976–1977Based in Leonding, AT· patent location history
1980–1990Patents assigned to BAYER AG (16)· patent assignee history
1980–1990Based in Leverkusen, DE· patent location history
1991–2015Patents assigned to LOHMANN THERAPIE SYST LTS (32)· patent assignee history
1991–2020Based in Neuwied, DE· patent location history
2008–2021Based in Andernach, DE· patent location history
2013Based in Worms-Herrnsheim, DE· patent location history
2018–2021Patents assigned to LTS LOHMANN THERAPIE SYSTEME AG (10)· patent assignee history
2018–2020Patents assigned to MUELLER WALTER (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| LOHMANN THERAPIE SYST LTS | 32 | 1991–2015 |
| BAYER AG | 16 | 1980–1990 |
| LTS LOHMANN THERAPIE SYSTEME AG | 10 | 2018–2021 |
| MUELLER WALTER | 4 | 2018–2020 |
| CHEMIE LINZ AG | 3 | 1976–1977 |
Locations
| Location | Patents | Span |
|---|---|---|
| Neuwied, DE | 35 | 1991–2020 |
| Leverkusen, DE | 16 | 1980–1990 |
| Andernach, DE | 11 | 2008–2021 |
| Leonding, AT | 3 | 1976–1977 |
| Worms-Herrnsheim, DE | 1 | 2013 |